On behalf of the American Association for Cancer Research (AACR), the oldest and largest cancer research organization in the world, we invite you to participate in the New Horizons in Cancer Research Conference: Bringing Cancer Discoveries to Patients, to be held November 12-15, 2015, in Shanghai, China.

The mission of the AACR is to prevent and cure cancer through research, education, communication, and collaboration. Through its programs and services, the AACR fosters research in cancer and related biomedical sciences; accelerates the dissemination of new research findings among scientists and others dedicated to the conquest of cancer; promotes science education and training; and advances the understanding of cancer etiology, prevention, diagnosis, and treatment throughout the world.

Inspired by the success of the historic event in 2014, the AACR is proud to announce the second edition of the New Horizons in Cancer Research Conference Series in China. As was the case last year, the meeting will highlight the latest and most exciting discoveries in major areas of cancer research, and will provide a unique opportunity for investigators from all over the world to discover, interact, and forge new scientific collaborations.

The meeting will serve as a dynamic platform for the advancement of cancer science and medicine, and for the establishment of new relationships on an international scale. The highly engaging and interactive four-day multidisciplinary program will cover the entire cancer research spectrum – from basic, to translational, to clinical – drawing on the latest findings presented at the 106th Annual Meeting of the AACR in Philadelphia, PA, April 18-22, 2015. The meeting will feature talks from an outstanding roster of international speakers and local experts.

Join us at the Shanghai Marriott Parkview Hotel to meet more than 1,200 attendees who are expected to attend this year’s Conference. Attendees are laboratory scientists and clinical investigators specializing in all aspects of cancer research, including experimental therapeutics, molecular targeted therapies, chemistry, molecular biology, genetics and epigenetics, immunology and immunotherapy, tumor biology, and clinical and translational research.


Yours sincerely,

Co-Chairpersons: